SCHEMBL355499

SCHEMBL355499

CCOC(=O)CCCCCn1c2ccccc2c(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 2/20 0.62
SLC6A4 P31645 2/20 0.56
SLC6A2 P23975 1/20 0.56
HRH1 P35367 1/20 0.56
PSEN1 P49768 1/20 0.56
PSEN2 P49810 1/20 0.56
APH1B Q8WW43 1/20 0.56
NCSTN Q92542 1/20 0.56
APH1A Q96BI3 1/20 0.56
PSENEN Q9NZ42 1/20 0.56
CTNNB1 P35222 1/20 0.55
KDM4E B2RXH2 1/20 0.54
HDAC1 Q13547 4/20 0.54
HDAC6 Q9UBN7 4/20 0.54
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004476 0.93 TNF (0.63) TNFPSEN1PSEN2APH1BNCSTN
SCHEMBL1004093 0.93 TNF (0.63) TNFPSEN1PSEN2APH1BNCSTN
SCHEMBL12938925 0.92 TNF (0.64) TNFPSEN1PSEN2APH1BNCSTN
SCHEMBL354741 0.90 TNF (0.53) TNFSLC6A4SLC6A2HRH1PSEN1
SCHEMBL354801 0.90 RXFP1 (0.55) TNFSLC6A4SLC6A2HRH1PSEN1
SCHEMBL355330 0.90 TNF (0.53) TNFSLC6A4SLC6A2HRH1PSEN1
SCHEMBL355062 0.89 PSEN1 (0.54) TNFSLC6A4SLC6A2HRH1PSEN1
SCHEMBL352528 0.86 MAPT (0.51) TNFPSEN1PSEN2APH1BNCSTN
SCHEMBL14266804 0.83 SMN1; SMN2 (0.47) TNFPSEN1PSEN2APH1BNCSTN
SCHEMBL353749 0.83 SMN1; SMN2 (0.49) TNFPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1649283-B1 METHOD FOR MEASURING AROMATASE ACTIVITY GE HEALTHCARE UK LTD (GB) 2014-06-18 EP disclosed
US-8334387-B2 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2012-12-18 US disclosed
US-8334387-B2 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2012-12-18 US disclosed
US-8334387-B2 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2012-12-18 US disclosed
US-20120015373-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS GE HEALTHCARE UK LIMITED (GB) 2012-01-19 US disclosed
US-8034558-B2 Incubating dye of given formula with biological material, measuring fluorescence lifetime; lectins/glycoproteins, biotin/streptavidin, DNA/RNA GE HEALTHCARE UK LIMITED (GB) 2011-10-11 US disclosed
US-20110014641-A1 METHOD FOR MEASURING AROMATASE ACTIVITY GE HEALTHCARE UK LIMITED (GB) 2011-01-20 US disclosed
US-20110014641-A1 METHOD FOR MEASURING AROMATASE ACTIVITY GE HEALTHCARE UK LIMITED (GB) 2011-01-20 US disclosed
US-20110014641-A1 METHOD FOR MEASURING AROMATASE ACTIVITY GE HEALTHCARE UK LIMITED (GB) 2011-01-20 US disclosed
US-7829714-B2 Method for measuring aromatase activity GE HEALTHCARE LIMITED (GB) 2010-11-09 US disclosed
US-7829714-B2 Method for measuring aromatase activity GE HEALTHCARE LIMITED (GB) 2010-11-09 US disclosed
US-20080139788-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS GE HEALTHCARE UK LIMITED (GB) 2008-06-12 US disclosed
US-20070184429-A1 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2007-08-09 US disclosed
US-20070184429-A1 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2007-08-09 US disclosed
US-20070184429-A1 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2007-08-09 US disclosed
EP-1649283-A2 METHOD FOR MEASURING AROMATASE ACTIVITY GE Healthcare UK Limited (GB) 2006-04-26 EP disclosed
WO-2005012901-A2 METHOD FOR MEASURING AROMATASE ACTIVITY AMERSHAM BIOSCIENCES UK LIMITED (GB) 2005-02-10 WO disclosed
US-20040191792-A1 Acridone derivatives as labels for fluorescence detection of target materials GE HEALTHCARE UK LIMITED (GB) 2004-09-30 US disclosed
EP-1392776-A2 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS Amersham Biosciences UK Limited (GB) 2004-03-03 EP disclosed
WO-2002099424-A2 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS AMERSHAM BIOSCIENCES UK LIMITED (GB) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139788-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS ACR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ARSA TNF 4339/4885SLC6A4 622/4885SLC6A2 1772/4885
US-20110014641-A1 METHOD FOR MEASURING AROMATASE ACTIVITY CYP19A1, CYP17A1, CYP21A2 TNF 3471/4885SLC6A4 1780/4885SLC6A2 2100/4885
US-20040191792-A1 Acridone derivatives as labels for fluorescence detection of target materials ACR, ARSA, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 TNF 4012/4885SLC6A4 637/4885SLC6A2 2468/4885
US-20070184429-A1 Method for measuring aromatase activity CYP19A1, CYP17A1, CYP21A2 TNF 3471/4885SLC6A4 1780/4885SLC6A2 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.